Chemotherapy strategies in the treatment of small cell lung cancer

被引：18
作者：
Popat, S
O'Brien, M
机构：
[1] Royal Marsden Hosp, Dept Med, Lung Unit, Sutton SM2 5PT, Surrey, England
[2] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England
来源：
ANTI-CANCER DRUGS | 2005年 / 16卷 / 04期
关键词：
chemotherapy; small cell lung cancer; treatment;
D O I：
10.1097/00001813-200504000-00002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Lung cancer is the most prevalent, yet most preventable malignancy worldwide. Given the tendency of small cell lung cancer (SCLC) to early relapse and its subsequent resistance to treatment, there is an urgent need to optimize standard treatment strategies and develop new treatments. Over the last decade, several strategies have been adopted and advances in the molecular biology of lung cancer have identified a number of targets for future therapy. In this article, we review chemotherapy strategies that have been evaluated in the management of patients with SCLC. (c) 2005 Lippincott Williams & Wilkins.
引用
收藏
页码：361 / 372
页数：12
相关论文
共 100 条
[81]  
SANDLER A, 2003, P AN M AM SOC CLIN, V22, P2537
[82]   Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593 - A phase III trial of the Eastern Cooperative Oncology Group [J].
Schiller, JH ;
Adak, S ;
Cella, D ;
DeVore, RF ;
Johnson, DH .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2114-2122
[83]   A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics [J].
Sculier, JP ;
Paesmans, M ;
Lecomte, J ;
Van Cutsem, O ;
Lafitte, JJ ;
Berghmans, T ;
Koumakis, G ;
Florin, MC ;
Thiriaux, J ;
Michel, J ;
Giner, V ;
Berchier, MC ;
Mommen, P ;
Ninane, V ;
Klastersky, J .
BRITISH JOURNAL OF CANCER, 2001, 85 (10) :1444-1451
[84]   Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer [J].
Sculier, JP ;
Paesmans, M ;
Bureau, G ;
Giner, V ;
Lecomte, J ;
Michel, J ;
Berchier, MC ;
VanCutsem, O ;
Kustner, U ;
Kroll, F ;
Sergysels, R ;
Mommen, P ;
Klastersky, J .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (08) :2337-2344
[85]  
SEIFTER EJ, 1988, SEMIN ONCOL, V15, P278
[86]   Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patinets with small-cell lung cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organisation for the Research and Treatment of Cancer [J].
Shepherd, FA ;
Giaccone, G ;
Seymour, L ;
Debruyne, C ;
Beziak, A ;
Hirsh, V ;
Smylie, M ;
Rubin, S ;
Martins, H ;
Lamont, A ;
Krzakowski, M ;
Sadura, A ;
Zee, B .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (22) :4434-4439
[87]  
SIEROCKI JS, 1979, CANCER TREAT REP, V63, P1593
[88]   Docetaxel and gemcitabine combination, as firs-tline treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group [J].
Skarlos, DV ;
Dimopoulos, AM ;
Kosmidis, P ;
Papakostas, P ;
Pavlidis, N ;
Bacoyiannis, C ;
Kiamouris, C ;
Klouvas, G ;
Gogas, H ;
Fountzilas, G ;
Samantas, E .
LUNG CANCER, 2003, 41 (01) :107-111
[89]   HIGH-DOSE CYCLOPHOSPHAMIDE WITH AUTOLOGOUS BONE-MARROW RESCUE AFTER CONVENTIONAL CHEMOTHERAPY IN THE TREATMENT OF SMALL CELL LUNG-CARCINOMA [J].
SMITH, IE ;
EVANS, BD ;
HARLAND, SJ ;
ROBINSON, BA ;
YARNOLD, JR ;
GLEES, JG ;
FORD, HT .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (02) :120-124
[90]   CARBOPLATIN (JM8) AS A SINGLE AGENT AND IN COMBINATION IN THE TREATMENT OF SMALL-CELL LUNG-CANCER [J].
SMITH, IE ;
EVANS, BD .
CANCER TREATMENT REVIEWS, 1985, 12 :73-75
12345678910